Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer

Human Pathology

Volumn 28, Issue 3, 1997, Pages 359-366

  Lindsay, Carol K ^b   Thorgeirsson, Unnur P ^a   Tsuda, Hitoshi ^b   Hirohashi, Setsuo ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

breast cancer; matrix metalloproteinases; tissue inhibitor of metalloproteinases 1

Indexed keywords

GELATINASE; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER INVASION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PROTEIN EXPRESSION; STROMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0031050875     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90136-2     Document Type: Article

References (43)

1. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochem Biophys Acta 948:67-85, 1988
2. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 6:121-125, 1990 (review).
3. Murphy G, Reynolds JJ, Hembry RM: Metalloproteinases and cancer invasion and metastasis. Int J Cancer 44:757-760, 1989
4. Stetler-Stevenson WG, Liotta LA, Kleiner DE: Extracellular matrix G: Role of metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441, 1993
5. DeClerck YA, Imren S: Protease inhibitors: Role and potential therapeutic use in human cancer. Eur J Cancer 30A: 2170-2180, 1994
6. Ogilvie DJ, HaileyJA, Juacaba SF, et al: Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. J Natl Cancer Inst 74:19-27, 1985
7. Tarin D, Hoyt BJ, Evans DJ: Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumors. Br J Cancer 46:266-278, 1982
8. Khokha R, Waterhouse P, Yagel S, et al: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity in Swiss 3T3 cells. Science 243:947-950, 1989
9. DeClerckYA, Perez N, Shimada H, et al: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708, 1992
10. Ballin M, Mackay AR, Hartzier JL, et al: Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues. Clin Exp Metastasis 9:179-189, 1991
11. Monteagudo C, Merino MJ, San-Juan J, et al: Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol 136:585-592, 1990
12. D'Errico A, Garbisa S, Liotta LA, et al: Augmentation of type IV collagenase, laminin receptor and Ki 67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4:239-246, 1991
13. Clavel C, Polette M, Doco M, et al: Immunolocalization of matrix metalloproteinases and their tissue inhibitor in human mammary pathology. Bull Cancer 79:261-270, 1992
14. Brown PD, Bloxidge RE, Anderson E, et al: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11:183-189, 1993
15. Davies B, Miles DW, Happerfield LC, et al: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67:1126-1131, 1993
16. Polette M, Clavel C, Cockett M, et al: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13:31-37, 1993
17. Poulsom R, Hanby AM, Pignatelli M, et al: Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46:429-436, 1993
18. Hoyhtya M, Fridman R, Komarek D, et al: Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 56:500-505, 1994
19. Visscher DW, Hoyhtya M, Ottosen SK, et al: Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339-344, 1994
20. Soini Y, Hurskainen T, Hoyhtya M, et al: 72 kDa and 92 kDa type IV collagenase, type IV collagen and laminin mRNAs in breast cancer: A study by in situ hybridization. J Histochem Cytochem 47:945, 1994
21. Heppner KJ, Matrisian LM, Jensen RA, et al: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:273-282, 1996
22. Lindsay CK, Thorgeirsson UP: Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Clin Exp Metastasis 13:381-388, 1995
23. Thorgeirsson UP, Turpeeniemi-Hujanen T, Williams JE, et al: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5:259-262, 1985
24. Ballin M, Gomez DE, Sinha CC, et al: Ras oncogene mediated induction of a 92 kDa metalloproteinase: Strong correlation with the malignant phenotype. Biochem Biophys Res Commun 154:832-838, 1988
25. Turpeeniemi-Hujanen, Thorgeirsson UP, Hart IR, et al: Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J Natl Cancer Inst 75:99-103, 1985
26. Schultz RM, Silberman S, Persky B, et al: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B 16-F10 melanoma cells. Cancer Res 48:5539-5545, 1988
27. Polette M, Clavel C, Birembaut P: Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol Res Pract 189:1052-1057, 1993
28. Kossakowska AE, Urbanski SJ, Watson A, et al: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncology Res 5:19-28, 1993
29. Stetler-Stevenson WG, Brown PD, Onisto M, et al: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938, 1990
30. Basset P, Bellocq JP, Wolf C, et al: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990
31. Sporn MB, Roberts AB, Wakefield LM, et al: Transforming growth factor beta: Biological function and chemical structure. Science 233:532-534, 1986
32. Folkman J: The influence of angiogenesis research on management of patients with breast cancer. Breast Cancer Res Treat 36:109-118, 1995
33. Horak ER, Leek R, Klenk N, et al: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124, 1992
34. Bosari S, Lee AKC, DeLellis A, et al: Microvessel quantitation and prognosis in invasive breast carcinoma. HUM PATHOL 23:755-761, 1992
35. Takigawa M, Nishida Y, Suzuki F, et al: Induction of angiogenesis in chick yolk-sac membranes by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). Biochem Biophys Res Commun 172:1264-1271, 1990
36. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992
37. Murphy AN, Unsworth EJ, Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial proliferation. J Cell Physiol 157:351-358, 1993
38. Fox SB, Gatter KC, Bicknell R, et al: Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 53:4161-4163, 1993
39. Johnson MD, Kim H-RC, Chesler L, et al: Inhibition of angiogcnesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194-202, 1994
40. Denhardt DT, Rajan S, Walther SE: Structure-function studies of mouse tissue inhibitor of metalloproteinases-1. Ann NY Acad Sci 732:65-72, 1994
41. Docherty AJP, Lyons A, Smith BJ, et al: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66-69, 1985
42. Bertaux B, Hornbeck W, Eisen AZ, et al: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685, 1991
43. Hayakawa T, Yamashita K, Tanzawa K, et al: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: A possible new growth factor in serum. FEBS Lett 298:29-32, 1992